{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:58:39Z","timestamp":1648904319291},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.rgmx.2016.12.004","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T18:17:55Z","timestamp":1489688275000},"page":"197-199","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Respuesta a Carmona R.: \u00bfEst\u00e1n realmente listos los anticuerpos anti-CdtB y antivinculina para emplearse en pacientes con diarrea en M\u00e9xico? A prop\u00f3sito de la colitis microsc\u00f3pica"],"prefix":"10.1016","volume":"82","author":[{"given":"M.","family":"Schmulson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Balbuena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Corona de Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2016.12.004_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rgmx.2016.12.004","article-title":"\u00bfEst\u00e1n realmente listos los anticuerpos anti-CdtB y anti-vinculina para emplearse en pacientes con diarrea en M\u00e9xico? A prop\u00f3sito de la colitis microsc\u00f3pica","volume":"82","author":"Carmona","year":"2017","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmx.2016.12.004_bib0070","first-page":"236","article-title":"Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico","volume":"81","author":"Schmulson","year":"2016","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0075","doi-asserted-by":"crossref","first-page":"e0126438","DOI":"10.1371\/journal.pone.0126438","article-title":"Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects","volume":"10","author":"Pimentel","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0080","doi-asserted-by":"crossref","first-page":"S952","DOI":"10.1016\/S0016-5085(16)33215-2","article-title":"Anti-vinculin and anti-CdtB antibodies in Mexican subjects: A case control study","volume":"4","author":"Remes Troche","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0085","series-title":"Rome IV Multidimensional clinical profile for functional gastrointestinal disorders","author":"Drossman","year":"2016"},{"key":"10.1016\/j.rgmx.2016.12.004_bib0090","first-page":"149","article-title":"The Mexican consensus on irritable bowel syndrome","volume":"81","author":"Carmona-S\u00e1nchez","year":"2016","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0095","doi-asserted-by":"crossref","first-page":"A350","DOI":"10.1016\/j.jval.2015.09.637","article-title":"Impact of a novel Ibs diagnostic blood panel for Mexico: Cost implications to the Mexican private practice for diarrhea predominant irritable bowel syndrome (Ibs-D)","volume":"18","author":"Schmulson","year":"2015","journal-title":"Value Health."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0100","series-title":"Bowel disorders. Rome IV Diagnostic algorithms for common GI symptoms","first-page":"37","author":"Mearin","year":"2016"},{"key":"10.1016\/j.rgmx.2016.12.004_bib0105","first-page":"427","article-title":"[Prevalence and clinical characteristics of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric trial. A report from the Mexican IBS Working Group] [art\u00edculo en espa\u00f1ol]","volume":"75","author":"Schmulson","year":"2010","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2016.12.004_bib0110","doi-asserted-by":"crossref","unstructured":"Amieva-Balmori M, Meixueiro A, Canton P, et al. Prevalence of irritable bowel syndrome in Mexico. A nationwide population based study using the Rome III questionnaire. Gastroenterology. 2014;146:S-535.","DOI":"10.1016\/S0016-5085(14)61937-5"},{"key":"10.1016\/j.rgmx.2016.12.004_bib0115","first-page":"39","article-title":"Prevalencia de colitis microsc\u00f3pica en pacientes con criterios de s\u00edndrome de intestino irritable","volume":"76","author":"Carmona-S\u00e1nchez","year":"2011","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmx.2016.12.004_bib0120","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00384-006-0258-7","article-title":"Microscopic colitides: A single center experience in Mexico","volume":"22","author":"Rubio-Tapia","year":"2007","journal-title":"Int J Colorectal Dis."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090617300356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090617300356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T14:20:50Z","timestamp":1535984450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090617300356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0375090617300356"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.12.004","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respuesta a Carmona R.: \u00bfEst\u00e1n realmente listos los anticuerpos anti-CdtB y antivinculina para emplearse en pacientes con diarrea en M\u00e9xico? A prop\u00f3sito de la colitis microsc\u00f3pica","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.12.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}